| Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic … CJL Murray, T Vos, I Zucker, S Zodpey, M Zhou, Z Zhao, K Zhang, ... The Lancet 392 (10159), 1789-1858, 2018 | 2714* | 2018 |
| Diagnostic methods for Helicobacter pylori infection: ideals, options, and limitations P Sabbagh, M Mohammadnia-Afrouzi, M Javanian, A Babazadeh, ... European Journal of Clinical Microbiology & Infectious Diseases 38, 55-66, 2019 | 194 | 2019 |
| Folate-conjugated nanoparticles as a potent therapeutic approach in targeted cancer therapy B Bahrami, M Mohammadnia-Afrouzi, P Bakhshaei, Y Yazdani, ... Tumor Biology 36, 5727-5742, 2015 | 126 | 2015 |
| Myeloid-derived suppressor cells in B cell malignancies Y Yazdani, M Mohammadnia-Afrouzi, M Yousefi, E Anvari, G Ghalamfarsa, ... Tumor Biology 36, 7339-7353, 2015 | 59 | 2015 |
| Influenza vaccination and Guillain–Barré syndrome: reality or fear A Babazadeh, Z Mohseni Afshar, M Javanian, M Mohammadnia-Afrouzi, ... Journal of translational internal medicine 7 (4), 137-142, 2019 | 52 | 2019 |
| MicroRNA signature of regulatory T cells in health and autoimmunity M Soltanzadeh-Yamchi, M Shahbazi, S Aslani, M Mohammadnia-Afrouzi Biomedicine & Pharmacotherapy 100, 316-323, 2018 | 52 | 2018 |
| Application of nanomedicine for crossing the blood–brain barrier: Theranostic opportunities in multiple sclerosis G Ghalamfarsa, M Hojjat-Farsangi, M Mohammadnia-Afrouzi, E Anvari, ... journal of immunotoxicology 13 (5), 603-619, 2016 | 46 | 2016 |
| Decrease of CD4+ CD25+ CD127low FoxP3+ regulatory T cells with impaired suppressive function in untreated ulcerative colitis patients M Mohammadnia-Afrouzi, A Zavaran Hosseini, A Khalili, S Abediankenari, ... Autoimmunity 48 (8), 556-561, 2015 | 45 | 2015 |
| Female unexplained infertility: a disease with imbalanced adaptive immunity M Ehsani, M Mohammadnia-Afrouzi, M Mirzakhani, S Esmaeilzadeh, ... Journal of human reproductive sciences 12 (4), 274-282, 2019 | 43 | 2019 |
| IL-21 and IL-21 receptor in the immunopathogenesis of multiple sclerosis G Ghalamfarsa, M Mahmoudi, M Mohammadnia-Afrouzi, Y Yazdani, ... Journal of immunotoxicology 13 (3), 274-285, 2016 | 43 | 2016 |
| Altered microRNA expression and immunosuppressive cytokine production by regulatory T cells of ulcerative colitis patients M Mohammadnia-Afrouzi, AZ Hosseini, A Khalili, S Abediankenari, ... Immunological investigations 45 (1), 63-74, 2016 | 39 | 2016 |
| TIM-3 as a marker of exhaustion in CD8+ T cells of active chronic hepatitis B patients H Mohammadizad, M Shahbazi, MRH Roushan, M Soltanzadeh-Yamchi, ... Microbial pathogenesis 128, 323-328, 2019 | 35 | 2019 |
| Inhibition of exosome release sensitizes U937 cells to PEGylated liposomal doxorubicin S Hekmatirad, M Moloudizargari, AA Moghadamnia, S Kazemi, ... Frontiers in Immunology 12, 692654, 2021 | 32 | 2021 |
| The exosome as a novel predictive/diagnostic biomarker of rejection in the field of transplantation M Mirzakhani, M Mohammadnia-Afrouzi, M Shahbazi, SA Mirhosseini, ... Clinical Immunology 203, 134-141, 2019 | 31 | 2019 |
| Mapping local patterns of childhood overweight and wasting in low-and middle-income countries between 2000 and 2017 Nature medicine 26 (5), 750-759, 2020 | 29 | 2020 |
| Evaluation of CD4+ CD25+ FoxP3+ regulatory T cells during treatment of patients with brucellosis. HR Mr, M Bayani, M Mohammadnia-Afrouzi, HR Nouri, S Ebrahimpour Journal of biological regulators and homeostatic agents 30 (3), 675-682, 2016 | 27 | 2016 |
| TIM‐3 as a potential exhaustion marker in CD4+ T cells of COVID‐19 patients Z Modabber, M Shahbazi, R Akbari, M Bagherzadeh, A Firouzjahi, ... Immunity, inflammation and disease 9 (4), 1707-1715, 2021 | 25 | 2021 |
| Immunological biomarkers of tolerance in human kidney transplantation: An updated literature review M Mirzakhani, M Shahbazi, F Oliaei, M Mohammadnia‐Afrouzi Journal of cellular physiology 234 (5), 5762-5774, 2019 | 25 | 2019 |
| Elevated levels of IL-2 and IL-21 produced by CD4+ T cells in inflammatory bowel disease. S Ebrahimpour, M Shahbazi, A Khalili, MT Tahoori, A Amari, B Aghili, ... Journal of biological regulators and homeostatic agents 31 (2), 279-287, 2017 | 25 | 2017 |
| Pronounce expression of Tim-3 and CD39 but not PD1 defines CD8 T cells in critical Covid-19 patients M Shahbazi, Z Moulana, M Sepidarkish, M Bagherzadeh, M Rezanejad, ... Microbial Pathogenesis 153, 104779, 2021 | 24 | 2021 |
